Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Peripheral Vascular Devices Market Summary

The global peripheral vascular devices market is expected to increase from USD 9,853.30 million in 2024 to USD 15,544.32 million by 2032, reflecting strong and sustained growth.

The global peripheral vascular devices market is growing at a CAGR of 5.92% during the forecast period from 2025 to 2032.

The market of peripheral vascular devices is being primarily driven by the growing instances of Peripheral Artery Disease (PAD) and vascular disorders and their associated risk factors, increasing preference for minimally invasive procedures, technological advancements in the product designs, and an increase in product development activities among the key market players.

The leading companies operating in the peripheral vascular devices market include Medtronic, Boston Scientific Corporation, B. Braun SE, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc, Abbott Laboratories, Cardiovascular Systems, Inc., AngioDynamics Inc, Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular, and others.

North America is expected to dominate the overall peripheral vascular devices market due to the high prevalence of peripheral artery disease, diabetes, and obesity, along with a rapidly aging population. The region benefits from advanced healthcare infrastructure, strong adoption of minimally invasive procedures, and favorable reimbursement policies that support device utilization. Additionally, the presence of leading medical device manufacturers and continuous product innovation further strengthen North America’s position as the leading market for peripheral vascular devices.

In the product type segment of the peripheral vascular devices market, the angioplasty stents category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Peripheral Vascular Devices Market

Growing instances of Peripheral Artery Disease (PAD) and vascular disorders and their associated risk factors leading to a surge in peripheral vascular devices: The rising prevalence of Peripheral Artery Disease (PAD) and other vascular disorders, driven by risk factors such as diabetes, obesity, hypertension, smoking, and an aging population, is significantly boosting the demand for peripheral vascular devices. Increasing cases of arterial blockages, aneurysms, and venous complications are creating a higher need for stents, angioplasty balloons, and atherectomy devices to restore blood flow and reduce complications. As early diagnosis and treatment awareness grow, healthcare providers are increasingly adopting advanced minimally invasive peripheral vascular devices, fueling market growth.

Increasing preference for minimally invasive procedures escalating the market of peripheral vascular devices: The growing preference for minimally invasive procedures is accelerating the market for peripheral vascular devices, as these techniques offer shorter recovery times, reduced hospital stays, lower risk of complications, and improved patient outcomes compared to traditional surgeries. Devices such as stents, angioplasty balloons, and EVAR systems are increasingly adopted in endovascular treatments, driving demand and expanding the market.

Technological advancement in product design: Technological advancements in product design are boosting the peripheral vascular devices market by enabling the development of next-generation stents, drug-eluting balloons, atherectomy systems, and EVAR devices that offer higher precision, better durability, and improved patient safety. Innovations such as bioresorbable materials, advanced coatings, and imaging-guided delivery systems enhance treatment outcomes and minimize complications, driving wider adoption of these devices in minimally invasive vascular interventions.

Peripheral Vascular Devices Market Report Segmentation

This peripheral vascular devices market report offers a comprehensive overview of the global peripheral vascular devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Percutaneous Transluminal Angioplasty Balloon Catheters [Drug-Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter], Angioplasty Stents [Drug-Eluting Stents, Bare-Metal Stents, and Expandable Stents], Plaque Modification Devices [Atherectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Vena cava Filters [Retrievable and Permanent], and Others), End-User (Hospitals, Specialty Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing peripheral vascular devices market.

Peripheral vascular devices are a range of medical tools and implants used to diagnose and treat diseases of the peripheral vascular system, which includes all the blood vessels outside of the heart and brain. These devices are crucial for restoring proper blood flow and managing conditions like peripheral artery disease (PAD), where plaque buildup narrows arteries.

The overall market for peripheral vascular devices is being strongly driven by the growing burden of Peripheral Artery Disease (PAD) and other vascular disorders, fueled by risk factors such as diabetes, hypertension, and obesity. Alongside this, the increasing preference for minimally invasive procedures is boosting the adoption of advanced devices like stents, angioplasty balloons, and EVAR systems due to their faster recovery and reduced complications. Continuous technological advancements in product design, including drug-eluting technologies, bioresorbable materials, and imaging-guided delivery systems, are further enhancing treatment outcomes. Additionally, intensified product development activities and innovations by key market players are expanding the portfolio of effective solutions, collectively propelling the growth of the peripheral vascular devices market.

Get More Insights into the Report @Peripheral Vascular Devices Market

What are the latest Peripheral Vascular Devices Market Dynamics and Trends?

The peripheral vascular devices market is witnessing robust growth, primarily driven by the rising prevalence of Peripheral Artery Disease (PAD), vascular disorders, and associated risk factors such as diabetes, obesity, hypertension, and smoking. The increasing global preference for minimally invasive procedures is further accelerating adoption, as patients and providers seek safer, quicker, and more effective treatment options.

According to DelveInsight’s 2024 analysis, nearly 621 million people worldwide live with heart and circulatory diseases, reflecting a massive and growing patient pool in need of advanced vascular interventions. Peripheral artery disease alone affects around 6.5 million adults (5.8%) aged 40 years or older globally, while the burden of atrial fibrillation is expected to surpass 12.5 million patients by 2030. Collectively, these statistics underscore the rising demand for treatment solutions such as stents, angioplasty balloons, atherectomy systems, and endovascular aneurysm repair (EVAR) devices.

The demand surge is further fueled by the clinical and economic advantages of minimally invasive endovascular procedures, which offer shorter recovery times, reduced hospital stays, fewer complications, and improved patient quality of life. These benefits are driving the transition from open surgeries to catheter-based interventions, making devices like drug-eluting stents, covered stents, drug-coated balloons, and thrombectomy systems integral to modern vascular care.

Moreover, technological advancements and regulatory approvals are expanding the treatment arsenal. For instance, in September 2024, Argon Medical Devices launched the CLEANER Vac™ Thrombectomy System, designed for the removal of blood clots from the peripheral venous vasculature. Such innovations, along with the increasing use of image-guided navigation systems and the development of next-generation bioresorbable scaffolds, are further enhancing procedural precision and outcomes.

Additionally, growing awareness campaigns for PAD, and increasing healthcare expenditure, particularly in emerging economies, are opening new growth opportunities.

In summary, the combination of a rapidly expanding patient pool, increasing adoption of minimally invasive interventions, continuous innovation in device technologies, and supportive healthcare policies is expected to drive sustained growth in the global peripheral vascular devices market during the forecast period.

However, the peripheral vascular devices market faces several key restraints and challenges that limit its growth and adoption. A major barrier is the high cost of devices and procedures, which makes advanced treatments less accessible, especially in developing countries with limited healthcare budgets. This is compounded by the stringent and complex regulatory landscape, which leads to lengthy and expensive approval processes and a risk of product recalls. Furthermore, reimbursement challenges from insurance providers and government programs can make it financially unviable for healthcare facilities to adopt new, expensive technologies. The market also faces competition from alternative treatments, such as traditional pharmacological therapies and open surgeries, which are still considered viable options for many patients. Lastly, a lack of specialized training and expertise among healthcare professionals, particularly in certain regions, can hinder the widespread use and adoption of these sophisticated devices.

Peripheral Vascular Devices Market Segment Analysis

Product Type (Percutaneous Transluminal Angioplasty Balloon Catheters [Drug-Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter], Angioplasty Stents [Drug-Eluting Stents, Bare-Metal Stents, and Expandable Stents], Plaque Modification Devices [Atherectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Vena cava Filters [Retrievable and Permanent], and Others), End-User (Hospitals, Specialty Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: Angioplasty Stents Category Dominates the Market

Within the angioplasty stents segment of the peripheral vascular devices market, the drug-eluting stents (DES) category is projected to dominate in 2024, accounting for an estimated 22% market share. DES are transforming vascular care by demonstrating superior clinical outcomes compared to traditional bare-metal stents (BMS). These advanced devices release pharmacological agents, such as paclitaxel or everolimus, directly at the site of arterial narrowing, effectively suppressing neointimal hyperplasia, reducing restenosis risk, and improving long-term vessel patency. This targeted approach not only minimizes the need for repeat revascularization procedures but also significantly enhances patient quality of life, making DES the preferred choice in managing complex vascular lesions associated with Peripheral Artery Disease (PAD).

The adoption of DES is being fueled by the growing prevalence of PAD, which continues to rise due to key risk factors including aging, diabetes, obesity, smoking, and hypertension. As healthcare systems worldwide face increasing clinical and economic burdens from recurrent interventions, DES provide durable and cost-effective treatment solutions, reducing downstream expenditures associated with hospital readmissions and re-interventions.

Technological innovations are also accelerating DES uptake. Next-generation DES platforms featuring bioresorbable polymers, thinner struts, enhanced radial strength, and improved deliverability have significantly improved procedural safety and long-term outcomes. The pipeline also includes fully bioresorbable scaffolds designed to provide temporary vessel support and then gradually dissolve, restoring natural vascular function, a major leap forward in PAD management.

Recent regulatory milestones highlight the growing clinical confidence in DES. For example, in April 2024, Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System, a dissolving stent for treating below-the-knee peripheral artery disease (PAD), received FDA approval in April 2024 and a CE Mark in Europe in August 2025. Specifically developed for patients with chronic limb-threatening ischemia (CLTI), this device maintains vessel patency while eventually resorbing, reducing long-term complications and offering new hope for high-risk patient populations.

In addition, increasing clinical trial evidence supporting DES efficacy, coupled with favorable reimbursement policies in major markets, is further strengthening their role as the standard of care for PAD.

Taken together, the combination of rising disease prevalence, proven clinical benefits, technological advancements, and supportive regulatory momentum is expected to solidify the dominance of DES within the angioplasty stents segment, thereby fueling overall growth in the peripheral vascular devices market.

By End-User: Hospitals Dominates the Market

Hospitals are projected to remain the dominant end-users in the peripheral vascular devices market, accounting for nearly 68% of the share in 2024. This leadership is attributed to several critical factors, including the availability of advanced healthcare infrastructure, well-equipped catheterization labs, and specialized vascular surgery units that enable the adoption of complex procedures such as angioplasty, atherectomy, and endovascular aneurysm repair (EVAR). Hospitals also benefit from the presence of highly skilled interventional cardiologists, vascular surgeons, and radiologists, which ensures better clinical outcomes and patient safety in managing Peripheral Artery Disease (PAD) and other vascular disorders.

Additionally, hospitals experience higher patient inflow, particularly for severe and advanced vascular cases requiring specialized care, making them the preferred setting for both elective and emergency interventions. The presence of favorable reimbursement frameworks in many regions further supports the uptake of advanced peripheral vascular devices in hospital settings, as insurers typically cover complex and high-cost procedures performed in accredited facilities. Moreover, hospitals are often the first to adopt newly approved technologies and innovative devices, supported by strong collaborations with medical device manufacturers and ongoing participation in clinical trials.

As a result, hospitals will continue to drive demand for peripheral vascular devices, reinforcing their position as the primary end-user segment throughout the forecast period.

Peripheral Vascular Devices Market Regional Analysis

North America Peripheral Vascular Devices Market Trends

North America is projected to dominate the global peripheral vascular devices market in 2024, holding approximately 41% of the total share. This dominance is projected to continue, with the region holding a significant share, approaching half of the total market, due to a confluence of powerful drivers. The high and growing prevalence of peripheral artery disease (PAD), fueled by an aging population and escalating rates of risk factors like diabetes and obesity, creates a massive and sustained demand for advanced treatment options.

The region's advanced healthcare infrastructure further solidifies its market leadership. North America is home to numerous state-of-the-art hospitals and specialized ambulatory surgical centers, all equipped with the latest technology to support the widespread adoption of minimally invasive procedures. This robust ecosystem is bolstered by the presence of major industry players like Medtronic and Johnson & Johnson (following its acquisition of Shockwave Medical), who drive constant innovation through heavy investment in research and development. Favorable reimbursement policies from both private and government insurers make these costly but life-saving procedures more accessible and financially viable for patients and healthcare providers alike.

Similarly, the Centers for Disease Control and Prevention (CDC) estimates that approximately 900,000 people are affected annually by deep vein thrombosis (DVT) or pulmonary embolism (PE) in the United States. These conditions are major contributors to morbidity, mortality, and healthcare costs, creating sustained demand for effective peripheral vascular interventions such as stents, thrombectomy systems, angioplasty balloons, and EVAR devices.

Innovation remains a cornerstone of this market's growth, with recent technological breakthroughs continually expanding treatment capabilities. For instance, in September 2024, Shockwave Medical launched its E8 Peripheral IVL Catheter in the U.S., a device specifically designed to treat heavily calcified lesions both above and below the knee. In March 2025, the company launched its Shockwave Javelin Peripheral IVL Catheter, a novel platform designed to cross and modify extremely narrowed, difficult-to-treat vessels. Such advancements are crucial for addressing complex PAD cases, reducing procedural risks, and dramatically improving patient outcomes.

In essence, North America's market leadership is a result of a powerful synergy between a large and aging patient population, a strong and supportive healthcare system, and a culture of continuous innovation. This convergence of factors ensures that the region will maintain its commanding position in the global peripheral vascular devices market for the foreseeable future.

Europe Peripheral Vascular Devices Market Trends

The European peripheral vascular devices market is a dynamic and growing segment driven by a perfect storm of an aging population, rising rates of chronic diseases, and a strong preference for minimally invasive treatments. The increasing prevalence of conditions like diabetes, hypertension, and obesity is a major catalyst, creating a steady and growing patient pool with peripheral artery disease (PAD) and other vascular issues. In response to this demand, the European healthcare sector is rapidly adopting advanced endovascular techniques, which are favored over traditional open surgeries due to their benefits of reduced patient trauma, shorter hospital stays, and faster recovery.

The European market is seeing a high rate of adoption for premium-priced, technologically advanced devices. This includes the growing use of drug-eluting balloons (DCBs) and intravascular lithotripsy (IVL) systems. These innovations are designed to provide more effective and durable treatment outcomes, particularly for complex and heavily calcified lesions, which were previously difficult to treat with conventional methods.

Key European countries like Germany, France, and the UK have well-developed healthcare systems that support the market. High levels of patient awareness, coupled with established clinical guidelines, promote the diagnosis and treatment of vascular diseases. While reimbursement policies can vary by country, many are supportive of advanced, high-value medical technologies, which encourages their use in clinical practice.

Furthermore, the market is highly competitive, with both global giants and specialized regional companies pushing for continuous product innovation, ensuring a steady stream of advanced devices to meet the evolving needs of European patients and healthcare providers.

Asia-Pacific Peripheral Vascular Devices Market Trends

The Asia-Pacific region is emerging as one of the fastest-growing and most promising markets for peripheral vascular devices. While it currently trails North America and Europe in overall market share, its rapid growth trajectory is undeniable, driven by a unique set of demographic, economic, and healthcare trends.

The most significant driver of the market is the massive and escalating prevalence of chronic diseases. The region is home to a large, aging population, and a rapidly changing lifestyle has led to a surge in risk factors for peripheral artery disease (PAD), including diabetes, obesity, and hypertension. This epidemiological shift is creating an unprecedented demand for vascular treatment, particularly in densely populated countries like China and India, which are expected to lead regional growth.

Who are the major players in the Peripheral Vascular Devices market?

The following are the leading companies in the peripheral vascular devices market. These companies collectively hold the largest market share and dictate industry trends.

Medtronic

Boston Scientific Corporation

B. Braun SE

Braile Biomedica

JOTEC GmbH

Edwards Life Sciences Corporation

LeMaitre Vascular, Inc.

W. L. Gore & Associates, Inc.

Abbott Laboratories

Cardiovascular Systems, Inc.

AngioDynamics Inc.

Control Medical Technology, LLC

Walk Vascular, LLC

Transit Scientific

Conic Vascular ACS Diagnostics

Others

How is the competitive landscape shaping the Peripheral Vascular Devices market?

The competitive landscape of the peripheral vascular devices market is highly competitive and is characterized by a mix of a few dominant global players and numerous smaller, specialized companies. The market is not a pure monopoly, but it is moderately concentrated, with a handful of multinational corporations, including Medtronic, Abbott Laboratories, and Boston Scientific Corporation, holding a significant portion of the total market share. These leaders leverage their strong brand recognition, extensive product portfolios (including stents, atherectomy devices, and catheters), and robust global distribution networks to maintain their dominance. They also invest heavily in research and development (R&D) to innovate with technologies like drug-eluting stents and intravascular lithotripsy, which helps them gain a competitive edge. This intense competition drives continuous innovation and is a key factor in shaping pricing strategies and market trends, while also posing a barrier to entry for smaller firms due to the high costs associated with R&D, clinical trials, and regulatory approvals.

Recent Developmental Activities in the Peripheral Vascular Devices Market

In June 2025, InspireMD announced that its CGuard® Prime Embolic Prevention System (EPS) received CE Mark approval under the European Medical Device Regulation (MDR) for use in stroke prevention.

In May 2025, Terumo Interventional Systems announced the early U.S. commercial availability of its FDA-approved ROADSAVER™ Carotid Stent System, designed for use with the Nanoparasol® Embolic Protection System.

In March 2025, Boston Scientific launched an updated FilterWire EZ embolic protection system in select European markets. The system features a wire with a 110-micron-pore filter at its tip, designed to capture embolic material while maintaining blood flow and reliably conforming to the artery walls.

In February 2025, Stryker completed the acquisition of Inari Medical, Inc., significantly strengthening its position in the thrombectomy market. Inari’s product portfolio, including the FlowTriever® System for pulmonary embolism and the ClotTriever® System for peripheral vessel thrombectomy, is highly complementary to Stryker’s existing Neurovascular business.

In February 2025, the Tendvia™ Pulmonary Artery Thrombectomy System from Shanghai Tendfo Medical Device Co., Ltd. received approval from the China National Medical Products Administration (NMPA). The device is indicated for transcatheter thrombectomy in patients with acute high-risk or intermediate-risk pulmonary embolism, offering a minimally invasive treatment option for these critical conditions.

In February 2023, Abbott Laboratories and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott Laboratories to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.

Peripheral Vascular Devices Market Segmentation

Peripheral Vascular Devices by Product Type Exposure

• Percutaneous Transluminal Angioplasty Balloon Catheters

Drug-Eluting Balloon Catheter

Cutting Balloon Catheter

Scoring Balloon Catheter

• Angioplasty Stents

Drug-Eluting Stents

Bare-Metal Stents

Expandable Stents

• Plaque Modification Devices

Atherectomy Devices

Thrombectomy Devices

• Hemodynamic Flow Alteration Devices

Embolic Protection Devices

Chronic Total Occlusion Devices

• Inferior Vena cava Filters

Retrievable

Permanent

• Others

Peripheral Vascular Devices End-Users Exposure

• Hospitals
• Specialty Centers
• Others

Peripheral Vascular Devices Geography Exposure

• North America Peripheral Vascular Devices Market

United States Peripheral Vascular Devices Market

Canada Peripheral Vascular Devices Market

Mexico Peripheral Vascular Devices Market

• Europe Peripheral Vascular Devices Market

United Kingdom Peripheral Vascular Devices Market

Germany Peripheral Vascular Devices Market

France Peripheral Vascular Devices Market

Italy Peripheral Vascular Devices Market

Spain Peripheral Vascular Devices Market

Rest of Europe Peripheral Vascular Devices Market

• Asia-Pacific Peripheral Vascular Devices Market

China Peripheral Vascular Devices Market

Japan Peripheral Vascular Devices Market

India Peripheral Vascular Devices Market

Australia Peripheral Vascular Devices

South Korea Peripheral Vascular Devices

Rest of Asia-Pacific Peripheral Vascular Devices

• Rest of the World Peripheral Vascular Devices Market

South America Peripheral Vascular Devices

Middle East Peripheral Vascular Devices

Africa Peripheral Vascular Devices

Impact Analysis

AI-Powered Innovations and Applications:

AI is set to fundamentally transform the peripheral vascular devices market by impacting every stage of the patient care journey. In diagnostics, AI-powered software can analyze medical images with superior speed and accuracy, enabling earlier and more precise detection of peripheral artery disease (PAD) and other vascular issues. This diagnostic power extends to treatment planning, where AI systems integrate a patient's clinical data to recommend the most suitable device and optimize procedural strategies, especially for complex cases, which helps to minimize risks and improve outcomes. Beyond the clinic, AI is enhancing device design and manufacturing by generating optimized designs for stents and grafts, and by improving quality control through automated vision systems. Finally, market players are using AI to gain a competitive edge by analyzing market trends and optimizing their operational strategies. Ultimately, AI's role is not just an incremental improvement but a fundamental shift towards more accurate diagnostics, personalized treatment, and accelerated innovation.

U.S. Tariff Impact Analysis on Peripheral Vascular Devices Market:

The imposition of U.S. tariffs on imported peripheral vascular devices can increase the cost of advanced stents, balloons, and atherectomy systems, affecting both manufacturers and healthcare providers. Higher import duties may lead to increased procedure costs, potentially limiting adoption, especially among smaller hospitals and clinics. For domestic manufacturers, tariffs can provide a competitive advantage by making locally produced devices relatively more affordable, but they may also disrupt global supply chains if key components are sourced internationally. Overall, tariffs can influence pricing strategies, market dynamics, and investment decisions within the U.S. peripheral vascular devices market, potentially slowing growth if cost pressures are passed on to healthcare providers and patients.

How This Analysis Helps Clients

Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.

Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.

Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.

Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Peripheral Vascular Devices market report study

Market size analysis for the current peripheral vascular devices market size (2024), and market forecast for 8 years (2025 to 2032)

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.

Key companies dominating the peripheral vascular devices market.

Various opportunities available for the other competitors in the peripheral vascular devices market space.

What are the top-performing segments in 2024How these segments will perform in 2032?

Which are the top-performing regions and countries in the current Peripheral vascular devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for the peripheral vascular devices market growth in the future?

Frequently Asked Questions for the Peripheral Vascular Devices Market

1. What is the growth rate of the peripheral vascular devices market?

The peripheral vascular devices market is estimated to grow at a CAGR of 5.92% during the forecast period from 2025 to 2032.

2. What is the market for peripheral vascular devices?

The peripheral vascular devices market was valued at USD 9,853.30 million in 2024, and is expected to reach USD 15,544.32 million by 2032.

3. Which region has the highest share in the peripheral vascular devices market?

North America is expected to dominate the overall peripheral vascular devices market due to the high prevalence of peripheral artery disease, diabetes, and obesity, along with a rapidly aging population. The region benefits from advanced healthcare infrastructure, strong adoption of minimally invasive procedures, and favorable reimbursement policies that support device utilization. Additionally, the presence of leading medical device manufacturers and continuous product innovation further strengthen North America’s position as the leading market for peripheral vascular devices

4. What are the drivers for the peripheral vascular devices market?

The overall market for peripheral vascular devices is being strongly driven by the growing burden of Peripheral Artery Disease (PAD) and other vascular disorders, fueled by risk factors such as diabetes, hypertension, and obesity. Alongside this, the increasing preference for minimally invasive procedures is boosting the adoption of advanced devices like stents, angioplasty balloons, and EVAR systems due to their faster recovery and reduced complications. Continuous technological advancements in product design, including drug-eluting technologies, bioresorbable materials, and imaging-guided delivery systems, are further enhancing treatment outcomes. Show more